查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855937

2025年全球眼科基因診斷市場報告

Ocular Genetic Diagnostic Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，眼科基因檢測市場呈現強勁成長勢頭，預計將從2024年的9.8億美元成長到2025年的10.7億美元，複合年成長率達9.7%。預測期內的成長主要歸功於分子診斷技術的早期應用、人們對遺傳性眼科疾病的認知不斷提高、學術和臨床研究的拓展、視網膜營養不良盛行率的上升以及對兒童基因檢測需求的成長。

預計未來幾年，眼科基因診斷市場將維持強勁成長，2029年市場規模將達到15.3億美元，複合年成長率（CAGR）為9.4%。預測期內的成長主要受以下因素驅動：對個人化眼科護理的需求不斷成長、面向消費者的基因檢測服務日益普及、基因治療試驗投資不斷增加、精準醫療舉措蓬勃發展以及人工智慧在基因數據解讀中的應用。預測期內的關鍵趨勢包括：基於人工智慧的基因分析應用日益廣泛、家用基因檢測套組的普及、產前眼科基因篩檢需求不斷成長、基因特異性診斷平台的開發以及雲端基礎基因數據儲存技術的進步。

眼科遺傳診斷是一門專注於檢測和分析與眼部健康和視力相關的基因變異的專業。它涉及對與眼科疾病相關的遺傳因素進行系統性檢測，目的是確定眼科疾病的遺傳基礎。

眼科遺傳診斷的主要檢測類型包括單基因檢測、基因組檢測、全外EXOME定序和全基因組定序。單基因檢測（也稱為單例檢測）一次評估一個特定基因，適用於臨床特徵和家族病史強烈提示基因突變的情況。相關技術包括定序、聚合酵素鏈鎖反應(PCR)、微陣列技術和新一代定序 (NGS)。應用領域包括視網膜疾病、白內障診斷、遺傳性眼科疾病和老齡化黃斑部病變，最終用戶包括醫院、診斷實驗室、學術機構和研究機構。

美國在2025年春季突然提高關稅，由此引發的貿易摩擦對醫療保健產業造成了嚴重衝擊，尤其對關鍵醫療設備、診斷試劑和藥品的供應造成了嚴重影響。醫院和醫療機構面臨進口手術器械、影像設備以及注射器、導管等耗材成本不斷上漲的困境。這些成本的增加加劇了醫療預算的緊張，導致一些醫療機構必須推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅也阻礙了必需藥品和醫療設備的生產，造成供應鏈瓶頸。為了應對這項挑戰，醫療產業正在積極調整籌資策略，盡可能地促進本地生產，並呼籲對緊急醫療產品實施關稅豁免。

本研究報告是商業研究公司（The Business Research Company）全新系列報告的一部分，提供眼科基因診斷市場統計數據，例如全球眼科基因診斷市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的眼科基因診斷市場細分、市場趨勢和商機，以及您在眼科基因診斷行業取得成功所需的數據。這張眼科基因診斷市場研究報告對行業現狀和未來發展趨勢進行了詳細分析，為您提供所需的一切資訊。

眼科疾病的日益普遍推動了眼科基因診斷市場的擴張。眼科疾病涵蓋多種影響眼睛結構和功能的疾病，若不及時治療，可能導致視力喪失甚至失明。眼部疾病的增加主要是因為長時間使用電子螢幕和電子設備，導致眼睛疲勞、乾眼症和其他視力障礙。眼科基因診斷透過早期識別遺傳因素、更好地了解疾病起源以及提高診斷準確性和最佳化患者護理策略，為這些疾病的治療提供支持。例如，美國盲人基金會（總部位於美國的視障人士支援組織）於2025年2月進行的一項調查發現，5,190萬18歲及以上的美國成年人報告存在某種形式的視覺障礙者障礙。其中，370萬人即使戴眼鏡也視力模糊，30.7萬人完全失明。其餘4,790萬人即使配戴矯正眼鏡也存在輕度視力障礙。視力障礙病例的增加導致眼科保健領域對基因診斷的需求不斷成長。

該市場中的企業正優先發展專業臨床服務，以改善遺傳性眼科疾病患者提供集中護理，將基因檢測、諮詢和個人化治療方案整合於同一環境中。此舉有助於更及時、更準確地識別遺傳性眼科疾病，並根據每位患者獨特的基因譜提供量身定做的治療。此類臨床服務反映了眼部遺傳學領域向精準醫療和以患者為中心的綜合護理模式發展的更廣泛趨勢。

2024年10月，專注於眼科治療的美國生物製藥公司Ocufire收購了Opus Genetics，收購金額未揭露。此次收購使Ocufire得以拓展其開發平臺，納入針對罕見遺傳性眼科疾病的基因治療計畫。該公司旨在透過整合其現有的先進藥物組合和早期基因療法，滿足視網膜退化性疾病領域尚未滿足的醫療需求。 Opus Genetics同樣位於美國，專注於開發治療遺傳性視網膜疾病（導致進行性視力喪失）的治療方法。

眼科基因診斷市場由提供分子診斷服務、基因諮詢服務、風險評估服務和客製化基因報告服務等服務的營業單位所獲得的收入組成。市場價值還包括服務提供者銷售的或包含在其服務產品中的任何相關產品的價值。眼科基因診斷市場還包括基因檢測套組、檢測試劑和耗材的銷售額。該市場的價值為“出廠價”，即製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球眼科基因診斷：PESTEL 分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 終端用戶產業分析
  • 全球眼科基因診斷市場：成長率分析
  • 全球眼科基因診斷市場表現：規模與成長，2019-2024年
  • 全球眼科基因診斷市場預測：規模與成長，2024-2029年，2034年預測
  • 全球眼科基因診斷：潛在市場規模 (TAM)

第6章 市場細分

  • 全球眼科基因診斷市場依檢測類型、表現及預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 單基因檢測
  • 小組測試
  • 全EXOME定序
  • 全基因組定序
  • 全球眼科基因診斷市場：依技術類型、表現及預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 定序技術
  • 聚合酵素鏈鎖反應（PCR）
  • 微陣列技術
  • 次世代定序儀（NGS）
  • 全球眼科基因診斷市場：依應用、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 視網膜疾病
  • 白內障診斷
  • 遺傳性眼科疾病
  • 老齡化黃斑部病變
  • 全球眼科基因診斷市場：依最終使用者、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 醫院
  • 診斷實驗室
  • 學術研究機構
  • 其他最終用戶
  • 全球眼科基因診斷市場：依單一基因檢測、類型、表現及預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 視網膜母細胞瘤基因檢測（RB1）
  • RPE65基因突變檢測
  • MYOC基因檢測（青光眼）
  • OPA1基因檢測（視神經萎縮）
  • BEST1基因檢測（最佳疾病）
  • 全球眼科基因診斷市場：依檢測項目、類型、表現及預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 遺傳性視網膜疾病 (IRD) 小組
  • 青光眼基因檢測
  • 黃斑部營養不良症小組
  • 視神經疾病專家小組
  • 症狀眼科疾病檢測組
  • 全球眼科基因診斷市場：按全EXOME定序 (WES)、類型、表現和預測進行細分，2019-2024 年、2024-2029 年預測、2034 年預測
  • 三重EXOME定序
  • 診斷性EXOME定序
  • EXOME再分析服務
  • 快速EXOME檢測
  • 產前外EXOME定序
  • 全球眼科基因診斷市場：按全基因組定序 (WGS)、類型、表現和預測進行細分，2019-2024 年、2024-2029 年預測、2034 年預測
  • 臨床全基因組定序
  • 快速全基因組定序
  • 兒童基因組定序
  • 產前全基因組定序
  • 罕見眼科疾病的基因組定序

第7章 區域和國家分析

  • 全球眼科基因診斷市場：依地區、績效及預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 全球眼科基因診斷市場：依國家、績效及預測分類，2019-2024 年、2024-2029 年預測、2034 年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 眼科基因診斷市場：競爭格局
  • 眼科基因診斷市場：公司概況
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • The Children's Hospital of Philadelphia Overview, Products and Services, Strategy and Financial Analysis
    • University of Iowa Hospitals and Clinics Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • PerkinElmer Inc.
  • Natera Inc.
  • Myriad Genetics Inc.
  • Fulgent Genetics Inc.
  • ARUP Laboratories Inc.
  • Invitae Corporation
  • Spark Therapeutics Inc.
  • GeneDx LLC
  • Blueprint Genetics Oy
  • Medgenome Labs Inc.
  • Centogene NV
  • PreventionGenetics LLC
  • Molecular Vision Laboratory LLC
  • Casey Eye Institute
  • Moorfields Eye Hospital & UCL Institute of Ophthalmology

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年眼科基因診斷市場：蘊藏新機會的國家
  • 2029年眼科基因診斷市場：新興細分市場機會
  • 2029年眼科基因診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38589

Ocular genetic diagnostics refers to the specialized field focused on detecting and analyzing inherited genetic variations linked to eye health and vision. It involves the systematic examination of genetic factors that contribute to ocular conditions, with the goal of identifying the hereditary basis of these disorders.

The primary test types in ocular genetic diagnostics include single gene testing, panel testing, whole exome sequencing, and whole genome sequencing. Single gene testing, also called singleton testing, evaluates one specific gene at a time, typically when a mutation is strongly suspected based on clinical features or family history. Technology types include sequencing technology, polymerase chain reaction (PCR), microarray technology, and next-generation sequencing (NGS). Applications include retinal disorders, cataract diagnosis, inherited ocular diseases, and age-related macular degeneration, with end users such as hospitals, diagnostic laboratories, academic institutions, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The ocular genetic diagnostic market research report is one of a series of new reports from The Business Research Company that provides ocular genetic diagnostic market statistics, including ocular genetic diagnostic industry global market size, regional shares, competitors with a ocular genetic diagnostic market share, detailed ocular genetic diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the ocular genetic diagnostic industry. The ocular genetic diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ocular genetic diagnostics market size has grown strongly in recent years. It will grow from $0.98 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period is attributed to the early adoption of molecular diagnostic techniques, rising awareness of inherited eye disorders, expansion of academic and clinical research, increasing incidence of retinal dystrophies, and growing demand for pediatric genetic testing.

The ocular genetic diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.53 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth during the forecast period is driven by rising demand for personalized ophthalmic care, expansion of direct-to-consumer genetic testing, increasing investments in gene therapy trials, growth of precision medicine initiatives, and the integration of artificial intelligence in genetic data interpretation. Key trends in the forecast period include greater use of artificial intelligence-powered genetic analysis, expansion of at-home genetic testing kits, rising demand for prenatal ocular genetic screening, development of gene-specific diagnostic platforms, and advancements in cloud-based genetic data storage.

The growing prevalence of eye diseases is contributing to the expansion of the ocular genetic diagnostic market. Eye diseases include a range of medical conditions that affect the eye's structure or function and can lead to vision loss or blindness if not properly treated. This increase in eye-related conditions is primarily driven by extended use of digital screens and electronic devices, which results in eye strain, dry eye, and other visual impairments. Ocular genetic diagnostics support the management of these conditions by identifying inherited genetic components early, providing a better understanding of disease origins, and improving diagnostic accuracy and patient care strategies. For example, in February 2025, a survey conducted by the American Foundation for the Blind, a United States-based organization supporting individuals with vision impairment, found that 51.9 million American adults aged 18 and older reported some degree of vision difficulty. Among them, 3.7 million have significant trouble seeing even while wearing glasses, and 307,000 are completely blind. The remaining 47.9 million experience mild visual difficulties despite using corrective lenses. This rise in vision problems is contributing to the growing demand for genetic diagnostics in ocular healthcare.

Companies involved in this market are prioritizing the development of specialized clinical services to improve early detection, diagnosis, and personalized treatment of hereditary eye conditions. Clinical services involve the professional evaluation, diagnosis, and management of patient health concerns. For instance, in October 2024, the Singapore National Eye Centre, a public-sector specialty eye hospital in Singapore, introduced the Ocular Genetics Service. This dedicated clinical program provides focused care for patients with inherited eye conditions, integrating genetic testing, counseling, and individualized treatment planning in one setting. The initiative allows for more timely and accurate identification of genetic eye disorders while offering care that aligns with the patient's unique genetic profile. This type of clinical service reflects a broader movement toward precision medicine and integrated, patient-centered care in the ocular genetics field.

In October 2024, Ocuphire Pharma Inc., a biopharmaceutical company based in the United States that specializes in ophthalmic treatments, acquired Opus Genetics Inc. for an undisclosed amount. This acquisition enables Ocuphire to broaden its research and development pipeline by incorporating gene therapy programs designed for rare genetic eye conditions. By combining its existing advanced-stage drug portfolio with early-stage genetic therapies, the company aims to address unmet needs in retinal degenerative diseases. Opus Genetics Inc., also based in the United States, focuses on the development of therapies for inherited retinal diseases associated with genes that cause progressive vision loss.

Major players in the ocular genetic diagnostic market are Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Illumina Inc., The Children's Hospital of Philadelphia, University of Iowa Hospitals and Clinics, PerkinElmer Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., ARUP Laboratories Inc., Invitae Corporation, Spark Therapeutics Inc., GeneDx LLC, Blueprint Genetics Oy, Medgenome Labs Inc., Centogene NV, PreventionGenetics LLC, Molecular Vision Laboratory LLC, Casey Eye Institute, and Moorfields Eye Hospital & UCL Institute of Ophthalmology.

North America was the largest region in the ocular genetic diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ocular genetic diagnostic report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ocular genetic diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ocular genetic diagnostic market consists of revenues earned by entities by providing services such as molecular diagnostic services, genetic counseling services, risk assessment services, and customized genetic report services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ocular genetic diagnostic market also includes sales of genetic testing kits, laboratory reagents, and consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ocular Genetic Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ocular genetic diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ocular genetic diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ocular genetic diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Single Gene Testing; Panel Testing; Whole Exome Sequencing; Whole Genome Sequencing
  • 2) By Technology Type: Sequencing Technology; Polymerase Chain Reaction (PCR); Microarray Technology; Next-Generation Sequencing (NGS)
  • 3) By Application: Retinal Disorders; Cataract Diagnosis; Inherited Ocular Disorders; Age-Related Macular Degeneration
  • 4) By End User: Hospitals; Diagnostic Laboratories; Academic And Research Institutes; Other End Users
  • Subsegments:
  • 1) By Single Gene Testing: Retinoblastoma Gene Testing (RB1); RPE65 Gene Mutation Testing; MYOC Gene Testing (Glaucoma); OPA1 Gene Testing (Optic Atrophy); BEST1 Gene Testing (Best Disease)
  • 2) By Panel Testing: Inherited Retinal Disease (IRD) Panels; Glaucoma Genetic Panels; Macular Dystrophy Panels; Optic Neuropathy Panels; Syndromic Ocular Disorder Panels
  • 3) By Whole Exome Sequencing (WES): Trio Exome Sequencing; Diagnostic Exome Sequencing; Exome Reanalysis Services; Rapid Exome Testing; Prenatal Exome Sequencing
  • 4) By Whole Genome Sequencing (WGS): Clinical Whole Genome Sequencing; Rapid Whole Genome Sequencing; Pediatric Genome Sequencing; Prenatal Whole Genome Sequencing; Ultra-Rare Eye Disease Genome Sequencing
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Quest Diagnostics Inc.; Illumina Inc.; The Children's Hospital of Philadelphia; University of Iowa Hospitals and Clinics; PerkinElmer Inc.; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; ARUP Laboratories Inc.; Invitae Corporation; Spark Therapeutics Inc.; GeneDx LLC; Blueprint Genetics Oy; Medgenome Labs Inc.; Centogene NV; PreventionGenetics LLC; Molecular Vision Laboratory LLC; Casey Eye Institute; Moorfields Eye Hospital & UCL Institute of Ophthalmology.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ocular Genetic Diagnostic Market Characteristics

3. Ocular Genetic Diagnostic Market Trends And Strategies

4. Ocular Genetic Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ocular Genetic Diagnostic Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Ocular Genetic Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Ocular Genetic Diagnostic Market Growth Rate Analysis
  • 5.4. Global Ocular Genetic Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Ocular Genetic Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Ocular Genetic Diagnostic Total Addressable Market (TAM)

6. Ocular Genetic Diagnostic Market Segmentation

  • 6.1. Global Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Gene Testing
  • Panel Testing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
  • 6.2. Global Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Technology
  • Polymerase Chain Reaction (PCR)
  • Microarray Technology
  • Next-Generation Sequencing (NGS)
  • 6.3. Global Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retinal Disorders
  • Cataract Diagnosis
  • Inherited Ocular Disorders
  • Age-Related Macular Degeneration
  • 6.4. Global Ocular Genetic Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Academic And Research Institutes
  • Other End Users
  • 6.5. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Single Gene Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retinoblastoma Gene Testing (RB1)
  • RPE65 Gene Mutation Testing
  • MYOC Gene Testing (Glaucoma)
  • OPA1 Gene Testing (Optic Atrophy)
  • BEST1 Gene Testing (Best Disease)
  • 6.6. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Panel Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inherited Retinal Disease (IRD) Panels
  • Glaucoma Genetic Panels
  • Macular Dystrophy Panels
  • Optic Neuropathy Panels
  • Syndromic Ocular Disorder Panels
  • 6.7. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Whole Exome Sequencing (WES), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trio Exome Sequencing
  • Diagnostic Exome Sequencing
  • Exome Reanalysis Services
  • Rapid Exome Testing
  • Prenatal Exome Sequencing
  • 6.8. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Whole Genome Sequencing (WGS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Whole Genome Sequencing
  • Rapid Whole Genome Sequencing
  • Pediatric Genome Sequencing
  • Prenatal Whole Genome Sequencing
  • Ultra-Rare Eye Disease Genome Sequencing

7. Ocular Genetic Diagnostic Market Regional And Country Analysis

  • 7.1. Global Ocular Genetic Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Ocular Genetic Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ocular Genetic Diagnostic Market

  • 8.1. Asia-Pacific Ocular Genetic Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ocular Genetic Diagnostic Market

  • 9.1. China Ocular Genetic Diagnostic Market Overview
  • 9.2. China Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ocular Genetic Diagnostic Market

  • 10.1. India Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ocular Genetic Diagnostic Market

  • 11.1. Japan Ocular Genetic Diagnostic Market Overview
  • 11.2. Japan Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ocular Genetic Diagnostic Market

  • 12.1. Australia Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ocular Genetic Diagnostic Market

  • 13.1. Indonesia Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ocular Genetic Diagnostic Market

  • 14.1. South Korea Ocular Genetic Diagnostic Market Overview
  • 14.2. South Korea Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ocular Genetic Diagnostic Market

  • 15.1. Western Europe Ocular Genetic Diagnostic Market Overview
  • 15.2. Western Europe Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ocular Genetic Diagnostic Market

  • 16.1. UK Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ocular Genetic Diagnostic Market

  • 17.1. Germany Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ocular Genetic Diagnostic Market

  • 18.1. France Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ocular Genetic Diagnostic Market

  • 19.1. Italy Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ocular Genetic Diagnostic Market

  • 20.1. Spain Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ocular Genetic Diagnostic Market

  • 21.1. Eastern Europe Ocular Genetic Diagnostic Market Overview
  • 21.2. Eastern Europe Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ocular Genetic Diagnostic Market

  • 22.1. Russia Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ocular Genetic Diagnostic Market

  • 23.1. North America Ocular Genetic Diagnostic Market Overview
  • 23.2. North America Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ocular Genetic Diagnostic Market

  • 24.1. USA Ocular Genetic Diagnostic Market Overview
  • 24.2. USA Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ocular Genetic Diagnostic Market

  • 25.1. Canada Ocular Genetic Diagnostic Market Overview
  • 25.2. Canada Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ocular Genetic Diagnostic Market

  • 26.1. South America Ocular Genetic Diagnostic Market Overview
  • 26.2. South America Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ocular Genetic Diagnostic Market

  • 27.1. Brazil Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ocular Genetic Diagnostic Market

  • 28.1. Middle East Ocular Genetic Diagnostic Market Overview
  • 28.2. Middle East Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ocular Genetic Diagnostic Market

  • 29.1. Africa Ocular Genetic Diagnostic Market Overview
  • 29.2. Africa Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ocular Genetic Diagnostic Market Competitive Landscape And Company Profiles

  • 30.1. Ocular Genetic Diagnostic Market Competitive Landscape
  • 30.2. Ocular Genetic Diagnostic Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. The Children's Hospital of Philadelphia Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. University of Iowa Hospitals and Clinics Overview, Products and Services, Strategy and Financial Analysis

31. Ocular Genetic Diagnostic Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. Natera Inc.
  • 31.3. Myriad Genetics Inc.
  • 31.4. Fulgent Genetics Inc.
  • 31.5. ARUP Laboratories Inc.
  • 31.6. Invitae Corporation
  • 31.7. Spark Therapeutics Inc.
  • 31.8. GeneDx LLC
  • 31.9. Blueprint Genetics Oy
  • 31.10. Medgenome Labs Inc.
  • 31.11. Centogene NV
  • 31.12. PreventionGenetics LLC
  • 31.13. Molecular Vision Laboratory LLC
  • 31.14. Casey Eye Institute
  • 31.15. Moorfields Eye Hospital & UCL Institute of Ophthalmology

32. Global Ocular Genetic Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ocular Genetic Diagnostic Market

34. Recent Developments In The Ocular Genetic Diagnostic Market

35. Ocular Genetic Diagnostic Market High Potential Countries, Segments and Strategies

  • 35.1 Ocular Genetic Diagnostic Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Ocular Genetic Diagnostic Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Ocular Genetic Diagnostic Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer